Use of IL-23 Inhibitors to Treat Plaque Psoriasis
Mechanisms of action, routes and frequencies of administration of the newest IL-23 inhibitors—tildrakizumab, guselkumab, and risankizumab.
▶︎
IL-23 Inhibitors and Other Emerging Psoriasis Treatments
▶︎
How to Treat the Root Cause of Psoriasis: The Gut Microbiome
▶︎
Psoriasis and beyond: targeting the IL-17 pathway
▶︎
Discussing Risankizumb, Differences in IL-23 Inhibitor Epitopes with Christopher Bunick, MD, PhD
▶︎
Skyrizi
▶︎
PSORIASIS (AVOID These 7 Things) 2026
▶︎
Family Matters: The Central Role of the IL-17 Family of Cytokines in Inflammatory Disease
▶︎
Risankizumab impresses in phase 2 psoriatic arthritis trial
▶︎
How To Treat Psoriasis Like A Dermatologist
▶︎
Angioedema Explained: Causes, Symptoms, and When Swelling Is Dangerous
▶︎
Safety and Efficacy of IL-23 Inhibitors in Plaque Psoriasis
▶︎
Automatic packaging machines and packaging systems for Kits
▶︎
Psoriasis Treatment | 5 Things I Would do if I Got Psoriasis Again
▶︎
All You Need to Know about Biologics - How They Work, When to Use Them and The Common Side Effects
▶︎
Q&A About Psoriatic Arthritis
▶︎
Optimizing Clinical Pathways to Achieve Functional Cure in CHB
▶︎
Eye to Market Episode 6: Designing and De-Risking Clinical Trials in Ophthalmology
▶︎
Schuppenflechte behandeln: Psoriasis gezielt mit Ernährung lindern | Die Ernährungs-Docs | NDR
▶︎
New Crohn's & Colitis Medications and IBD Treatments on the Horizon
▶︎